医学
冲程(发动机)
免疫系统
中枢神经系统
临床试验
抗生素
病变
并发症
脑缺血
神经保护
缺血
免疫学
重症监护医学
内科学
外科
工程类
微生物学
生物
机械工程
作者
Ulrich Dirnagl,Juliane Klehmet,Johann Braun,Hendrik Harms,Christian Meisel,Tjalf Ziemssen,Konstantin Prass,Andreas Meisel
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2007-02-01
卷期号:38 (2): 770-773
被引量:473
标识
DOI:10.1161/01.str.0000251441.89665.bc
摘要
Stroke affects the normally well-balanced interplay of the 2 supersystems: the nervous and the immune system. Recent research elucidated some of the involved signals and mechanisms and, importantly, was able to demonstrate that brain-immune interactions are highly relevant for functional outcome after stroke. Immunodepression after stroke increases the susceptibility to infection, the most relevant complication in stroke patients. However, immunodepression after stroke may also have beneficial effects, for example, by suppressing autoaggressive responses during lesion-induced exposure of central nervous system-specific antigens to the immune system. Thus, before immunomodulatory therapy can be applied to stroke patients, we need to understand better the interaction of brain and immune system after focal cerebral ischemia. Until then, anticipating an important consequence of stroke-induced immunodepression, bacterial infection, preventive antibiotic strategies have been proposed. In mouse experiments, preventive antibiotic treatment dramatically improves mortality and outcome. Results of clinical studies on this issue are contradictory at present, and larger trials are needed to settle the question whether (and which) stroke patients should be preventively treated. Nevertheless, clinical evidence is emerging demonstrating that stroke-induced immunodepression in humans not only exists, but has very similar features to those characterized in rodent experiments.
科研通智能强力驱动
Strongly Powered by AbleSci AI